Computational Approaches in the Discovery and Development of Therapeutic and Prophylactic Agents for Viral Diseases

Title:Computational Approaches in the Discovery and Development of Therapeutic and Prophylactic Agents for Viral Diseases

Volume: 22 Issue: 26

Author(s): Anand Gaurav*, Neetu Agrawal, Mayasah Al-Nema and Vertika Gautam

Affiliation:

• Faculty of Pharmaceutical Sciences, UCSI University, Taman Connaught, Cheras, Kuala Lumpur, 56000, Malaysia

Keywords: Virus, HIV, SARS-CoV-2, HPV, Dengue, Docking, Molecular dynamics, QSAR, Pharmacophore, Virtual screening, Epitope, Vaccines, Reverse vaccinology.

Abstract: Over the last two decades, computational technologies have played a crucial role in antiviral drug development. Whenever a virus spreads and becomes a threat to global health, it brings along the challenge of developing new therapeutics and prophylactics. Computational drug and vaccine discovery has evolved quickly over the years. Some interesting examples of computational drug discovery are anti-AIDS drugs, where HIV protease and reverse transcriptase have been targeted by agents developed using computational methods. Various computational methods that have been applied to anti-viral research include ligand-based methods that rely on known active compounds, i.e., pharmacophore modeling, machine learning or classical QSAR; structure-based methods that rely on an experimentally determined 3D structure of the targets, i.e., molecular docking and molecular dynamics and methods for the development of vaccines such as reverse vaccinology; structural vaccinology and vaccine epitope prediction. This review summarizes these approaches to battle viral diseases and underscores their importance for anti-viral research. We discuss the role of computational methods in developing small molecules and vaccines against human immunodeficiency virus, yellow fever, human papilloma virus, SARS-CoV-2, and other viruses. Various computational tools available for the abovementioned purposes have been listed and described. A discussion on applying artificial intelligence-based methods for antiviral drug discovery has also been included.

Cite this article as:

Gaurav Anand*, Agrawal Neetu, Al-Nema Mayasah and Gautam Vertika, Computational Approaches in the Discovery and Development of Therapeutic and Prophylactic Agents for Viral Diseases, Current Topics in Medicinal Chemistry 2022; 22 (26) . https://dx.doi.org/10.2174/1568026623666221019110334